首页|Cyclophosphamide, hydroxycyclophosphamide and carboxyethyl phosphoramide mustard quantification with liquid chromatography mass spectrometry in a single run human plasma samples: A rapid and sensitive method development

Cyclophosphamide, hydroxycyclophosphamide and carboxyethyl phosphoramide mustard quantification with liquid chromatography mass spectrometry in a single run human plasma samples: A rapid and sensitive method development

扫码查看
原文链接
  • NSTL
  • Elsevier
A novel method for simultaneous quantification of cyclophosphamide along with its two major metabolites namely 4-hydroxycyclophosphamide (HCy) and carboxyethyl phosphoramide mustard (CEPM) in a single sample run was demonstrated in the present study. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) instrument was used for analysis. Semicarbazide was used as a stabilizing agent for HCy whereas ifosfamide, hexamethyl phosphoramide mustard and deuterated CEPM were the internal standards for quantification of Cy, HCy and CEPM respectively. Chromatographic separation was achieved by Chromsystems C18 reverse-phase column (50 mm x 4.6 mm, particle size 3.2 mu m). The mobile phase was composed of eluent A (2 mM ammonium acetate in water with 2% formic acid) and eluent B (100 % acetonitrile). The flow rate was 1 ml/min. Linearity of the assay was assured in the range of 19.53 ng/ml to 10,000 ng/ml concentration in human plasma, which is adequate for pharmacokinetic studies of any dose Cy used clinically. The quality control(QC) accuracy was between 99.58% and 101.62%, 97.85% to 103.53% and 99.64% to 100.10% for Cy, HCy and CEPM respectively. Precision limits for QC samples were between 3.9% and 9.4%, 5.2% to 8.9% and 1.8% to 9.2% respectively. The analytical method was validated in ten leukaemia patients undergoing haploidentical hematopoietic cell transplantation.

Carboxyethyl phosphoramide mustardHydroxy cyclophosphamideCyclophosphamideLiquid chromatography mass spectrometryPost transplantHEMATOPOIETIC-CELL TRANSPLANTATIONCONDITIONING REGIMENSLIVER TOXICITY4-HYDROXYCYCLOPHOSPHAMIDEPHARMACOKINETICSMETABOLITEQUANTITATIONBUSULFANMARROW

Kasudhan, Kripa Shanker、Patial, Ajay、Mehra, Nancy、Attri, Savita Verma、Malhotra, Pankaj、Pattanaik, Smita、Lad, Deepesh、Patil, Amol N.

展开 >

PGIMER

2022

10.1016/j.jchromb.2022.123228

Journal of chromatography

Journal of chromatography

ISSN：1570-0232
年,卷(期)：2022.1198
  • 1
  • 22